Showing all 5 results
Repaglinide and Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the absolute chemical stability of the combined formulation.
Active Ingredient Strength Primary Clinical Function Repaglinide USP/Ph.Eur. 1 mg / 2 mg Short-acting meglitinide for rapid post-prandial (after-meal) insulin stimulation. Metformin Hydrochloride USP/Ph.Eur. 500 mg Global Clinical Standard: Biguanide for hepatic glucose suppression and insulin sensitization. Excipients Microcrystalline Cellulose / Povidone K30 / Croscarmellose Sodium / Poloxamer / Magnesium Stearate Diluent / Binder / Superdisintegrant / Surfactant (Engineered for immediate gastric dissolution and synchronized dual-absorption) *Pack Sizes: 10×10 or 3×10 Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens tied directly to meal times).
Repaglinide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly sensitive meglitinide API.
Active Ingredient Strength Primary Clinical Function Repaglinide USP/Ph.Eur. 0.5 mg Base titration unit for treatment-naive patients or those with severe renal/hepatic impairment. Repaglinide USP/Ph.Eur. 1 mg / 2 mg Global Clinical Standard: Advanced maintenance doses for rapid post-prandial insulin stimulation. Excipients Microcrystalline Cellulose / Calcium Hydrogen Phosphate / Meglumine / Poloxamer / Magnesium Stearate Diluent / Stabilizer / Surfactant / Lubricant (Engineered for immediate gastric dissolution and ultra-fast systemic absorption) *Pack Sizes: 10×10 or 3×10 Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens tied directly to meal times).
Saxagliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Saxagliptin (as Hydrochloride) INN/Ph.Eur. 2.5 mg Target dose for patients with moderate/severe renal impairment or those taking strong CYP3A4 inhibitors. Saxagliptin (as Hydrochloride) INN/Ph.Eur. 5 mg Global Clinical Standard: Maximum adult daily dose for the maintenance of Type 2 Diabetes. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Diluent / Binder / Superdisintegrant (Engineered for immediate gastric dissolution and optimal bioavailability) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens).
Teneligliptin 20Mg + Metformin 500Mg Tablet Sustained Release
FreeA Teneligliptin 20mg + Metformin 500mg Sustained Release (SR) tablet is a combination antidiabetic medication used to manage type 2 diabetes mellitus when diet and exercise alone are insufficient.
Teneligliptin Tablet
FreeA Teneligliptin 20mg tablet is a modern oral antidiabetic medication belonging to the DPP-4 inhibitor (dipeptidyl peptidase-4) class, used primarily to manage type 2 diabetes mellitus.
